Related Content
- As innovaters prep for patent cliff, generics prosper from patent losses
- Medication adherence could be blockbuster for specialty
- Adherence is boosted by face-to-face contact, study finds
- PhRMA: Nearly 300 preventive medicines for heart disease, stroke in development
- Senator to float bill to address drug shortages
BENTONVILLE, Ark. — Walmart and Sam's Club will be among the first retailers to offer a generic version of an antiplatelet drug.
Clopidogrel, the generic version of Plavix, will be available at both banners pharmacies on May 19. The patent for the Bristol-Myers Squibb/Sanofi drug officially expires Thursday.
"Many of our customers struggle with the cost of health care in America and forego filling prescriptions to make ends meet," said John Agwunobi, president of Walmart U.S. health and wellness. "Walmart is focused on bringing our customers the lowest prices on the products and services they need to stay healthy, including aggressively delivering new generic medications as they are released."
Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.
